UK markets close in 5 hours 17 minutes
  • FTSE 100

    6,663.13
    +12.25 (+0.18%)
     
  • FTSE 250

    21,218.21
    -78.02 (-0.37%)
     
  • AIM

    1,164.75
    -8.64 (-0.74%)
     
  • GBP/EUR

    1.1567
    -0.0030 (-0.26%)
     
  • GBP/USD

    1.3806
    -0.0087 (-0.63%)
     
  • BTC-GBP

    34,292.36
    -1,631.32 (-4.54%)
     
  • CMC Crypto 200

    947.03
    -40.18 (-4.07%)
     
  • S&P 500

    3,768.47
    -51.25 (-1.34%)
     
  • DOW

    30,924.14
    -345.95 (-1.11%)
     
  • CRUDE OIL

    64.99
    +1.16 (+1.82%)
     
  • GOLD FUTURES

    1,691.40
    -9.30 (-0.55%)
     
  • NIKKEI 225

    28,864.32
    -65.79 (-0.23%)
     
  • HANG SENG

    29,098.29
    -138.50 (-0.47%)
     
  • DAX

    13,953.41
    -102.93 (-0.73%)
     
  • CAC 40

    5,799.59
    -31.06 (-0.53%)
     

Global Microbial Identification Industry

ReportLinker
·22-min read

Global Microbial Identification Market to Reach US$3. 4 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Microbial Identification estimated at US$2. 4 Billion in the year 2020, is projected to reach a revised size of US$3.

New York, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Microbial Identification Industry" - https://www.reportlinker.com/p05957365/?utm_source=GNW
4 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027.Instruments, one of the segments analyzed in the report, is projected to grow at a 3.4% CAGR to reach US$1.4 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 7% CAGR for the next 7-year period. This segment currently accounts for a 34.9% share of the global Microbial Identification market.

The U.S. Accounts for Over 29.4% of Global Market Size in 2020, While China is Forecast to Grow at a 4.8% CAGR for the Period of 2020-2027

The Microbial Identification market in the U.S. is estimated at US$707 Million in the year 2020. The country currently accounts for a 29.44% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$606 Million in the year 2027 trailing a CAGR of 4.9% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR while Rest of European market (as defined in the study) will reach US$606 Million by the year 2027.

Services Segment Corners a 20.1% Share in 2020

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$387.5 Million in the year 2020 will reach a projected size of US$565.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$395.4 Million by the year 2027.We bring years of research experience to this 6th edition of our report. The 185-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Becton, Dickinson and Company

  • Biolog, Inc.

  • bioMerieux SA

  • Bruker Corporation

  • Charles River Laboratories International, Inc.

  • Danaher Corporation

  • Eurofins Scientific SE

  • Merck KgaA

  • Shimadzu Corporation

  • Thermo Fisher Scientific, Inc.

  • Wickham Laboratories Ltd.




Read the full report: https://www.reportlinker.com/p05957365/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Microbial Identification Competitor Market Share Scenario
Worldwide (in %): 2018E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Microbial
Identification by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2018 through 2027

Table 2: World Historic Review for Microbial Identification by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 3: World 15-Year Perspective for Microbial Identification
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2018 & 2027

Table 4: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 5: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 6: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 7: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 8: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 9: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 10: World Current & Future Analysis for Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 11: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 12: World 15-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 13: World Current & Future Analysis for Hospitals,
Diagnostic Laboratories, & Blood Banks by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2018 through 2027

Table 14: World Historic Review for Hospitals, Diagnostic
Laboratories, & Blood Banks by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 15: World 15-Year Perspective for Hospitals, Diagnostic
Laboratories, & Blood Banks by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

Table 16: World Current & Future Analysis for Food
Manufacturing Companies by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2018 through 2027

Table 17: World Historic Review for Food Manufacturing
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 18: World 15-Year Perspective for Food Manufacturing
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2018 & 2027

Table 19: World Current & Future Analysis for Beverage
Manufacturers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2018 through
2027

Table 20: World Historic Review for Beverage Manufacturers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 21: World 15-Year Perspective for Beverage Manufacturers
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 22: World Current & Future Analysis for Pharmaceutical
Companies & CROs by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2018 through 2027

Table 23: World Historic Review for Pharmaceutical Companies &
CROs by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 24: World 15-Year Perspective for Pharmaceutical
Companies & CROs by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2018 & 2027

Table 25: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 26: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 27: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Microbial Identification Market Share (in %) by Company:
2018 & 2027
Market Analytics
Table 28: USA Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 29: USA Historic Review for Microbial Identification by
Product & Service - Instruments, Consumables and Services
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2017

Table 30: USA 15-Year Perspective for Microbial Identification
by Product & Service - Percentage Breakdown of Value Sales for
Instruments, Consumables and Services for the Years 2012,
2018 & 2027

Table 31: USA Current & Future Analysis for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 32: USA Historic Review for Microbial Identification by
End-Use - Hospitals, Diagnostic Laboratories, & Blood Banks,
Food Manufacturing Companies, Beverage Manufacturers,
Pharmaceutical Companies & CROs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 33: USA 15-Year Perspective for Microbial Identification
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Laboratories, & Blood Banks, Food Manufacturing
Companies, Beverage Manufacturers, Pharmaceutical Companies &
CROs and Other End-Uses for the Years 2012, 2018 & 2027

CANADA
Table 34: Canada Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 35: Canada Historic Review for Microbial Identification
by Product & Service - Instruments, Consumables and Services
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2017

Table 36: Canada 15-Year Perspective for Microbial
Identification by Product & Service - Percentage Breakdown of
Value Sales for Instruments, Consumables and Services for the
Years 2012, 2018 & 2027

Table 37: Canada Current & Future Analysis for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 38: Canada Historic Review for Microbial Identification
by End-Use - Hospitals, Diagnostic Laboratories, & Blood Banks,
Food Manufacturing Companies, Beverage Manufacturers,
Pharmaceutical Companies & CROs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 39: Canada 15-Year Perspective for Microbial
Identification by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories, & Blood Banks, Food
Manufacturing Companies, Beverage Manufacturers, Pharmaceutical
Companies & CROs and Other End-Uses for the Years 2012, 2018 &
2027

JAPAN
Table 40: Japan Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 41: Japan Historic Review for Microbial Identification by
Product & Service - Instruments, Consumables and Services
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2017

Table 42: Japan 15-Year Perspective for Microbial
Identification by Product & Service - Percentage Breakdown of
Value Sales for Instruments, Consumables and Services for the
Years 2012, 2018 & 2027

Table 43: Japan Current & Future Analysis for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 44: Japan Historic Review for Microbial Identification by
End-Use - Hospitals, Diagnostic Laboratories, & Blood Banks,
Food Manufacturing Companies, Beverage Manufacturers,
Pharmaceutical Companies & CROs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 45: Japan 15-Year Perspective for Microbial
Identification by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories, & Blood Banks, Food
Manufacturing Companies, Beverage Manufacturers, Pharmaceutical
Companies & CROs and Other End-Uses for the Years 2012, 2018 &
2027

CHINA
Table 46: China Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 47: China Historic Review for Microbial Identification by
Product & Service - Instruments, Consumables and Services
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2017

Table 48: China 15-Year Perspective for Microbial
Identification by Product & Service - Percentage Breakdown of
Value Sales for Instruments, Consumables and Services for the
Years 2012, 2018 & 2027

Table 49: China Current & Future Analysis for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 50: China Historic Review for Microbial Identification by
End-Use - Hospitals, Diagnostic Laboratories, & Blood Banks,
Food Manufacturing Companies, Beverage Manufacturers,
Pharmaceutical Companies & CROs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 51: China 15-Year Perspective for Microbial
Identification by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories, & Blood Banks, Food
Manufacturing Companies, Beverage Manufacturers, Pharmaceutical
Companies & CROs and Other End-Uses for the Years 2012, 2018 &
2027

EUROPE
Market Facts & Figures
European Microbial Identification Market: Competitor Market
Share Scenario (in %) for 2018 & 2027
Market Analytics
Table 52: Europe Current & Future Analysis for Microbial
Identification by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2018 through 2027

Table 53: Europe Historic Review for Microbial Identification
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2017

Table 54: Europe 15-Year Perspective for Microbial
Identification by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2018 & 2027

Table 55: Europe Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 56: Europe Historic Review for Microbial Identification
by Product & Service - Instruments, Consumables and Services
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2017

Table 57: Europe 15-Year Perspective for Microbial
Identification by Product & Service - Percentage Breakdown of
Value Sales for Instruments, Consumables and Services for the
Years 2012, 2018 & 2027

Table 58: Europe Current & Future Analysis for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 59: Europe Historic Review for Microbial Identification
by End-Use - Hospitals, Diagnostic Laboratories, & Blood Banks,
Food Manufacturing Companies, Beverage Manufacturers,
Pharmaceutical Companies & CROs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 60: Europe 15-Year Perspective for Microbial
Identification by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories, & Blood Banks, Food
Manufacturing Companies, Beverage Manufacturers, Pharmaceutical
Companies & CROs and Other End-Uses for the Years 2012, 2018 &
2027

FRANCE
Table 61: France Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 62: France Historic Review for Microbial Identification
by Product & Service - Instruments, Consumables and Services
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2017

Table 63: France 15-Year Perspective for Microbial
Identification by Product & Service - Percentage Breakdown of
Value Sales for Instruments, Consumables and Services for the
Years 2012, 2018 & 2027

Table 64: France Current & Future Analysis for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 65: France Historic Review for Microbial Identification
by End-Use - Hospitals, Diagnostic Laboratories, & Blood Banks,
Food Manufacturing Companies, Beverage Manufacturers,
Pharmaceutical Companies & CROs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 66: France 15-Year Perspective for Microbial
Identification by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories, & Blood Banks, Food
Manufacturing Companies, Beverage Manufacturers, Pharmaceutical
Companies & CROs and Other End-Uses for the Years 2012, 2018 &
2027

GERMANY
Table 67: Germany Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 68: Germany Historic Review for Microbial Identification
by Product & Service - Instruments, Consumables and Services
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2017

Table 69: Germany 15-Year Perspective for Microbial
Identification by Product & Service - Percentage Breakdown of
Value Sales for Instruments, Consumables and Services for the
Years 2012, 2018 & 2027

Table 70: Germany Current & Future Analysis for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 71: Germany Historic Review for Microbial Identification
by End-Use - Hospitals, Diagnostic Laboratories, & Blood Banks,
Food Manufacturing Companies, Beverage Manufacturers,
Pharmaceutical Companies & CROs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 72: Germany 15-Year Perspective for Microbial
Identification by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories, & Blood Banks, Food
Manufacturing Companies, Beverage Manufacturers, Pharmaceutical
Companies & CROs and Other End-Uses for the Years 2012, 2018 &
2027

ITALY
Table 73: Italy Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 74: Italy Historic Review for Microbial Identification by
Product & Service - Instruments, Consumables and Services
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2017

Table 75: Italy 15-Year Perspective for Microbial
Identification by Product & Service - Percentage Breakdown of
Value Sales for Instruments, Consumables and Services for the
Years 2012, 2018 & 2027

Table 76: Italy Current & Future Analysis for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 77: Italy Historic Review for Microbial Identification by
End-Use - Hospitals, Diagnostic Laboratories, & Blood Banks,
Food Manufacturing Companies, Beverage Manufacturers,
Pharmaceutical Companies & CROs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 78: Italy 15-Year Perspective for Microbial
Identification by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories, & Blood Banks, Food
Manufacturing Companies, Beverage Manufacturers, Pharmaceutical
Companies & CROs and Other End-Uses for the Years 2012, 2018 &
2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 80: UK Historic Review for Microbial Identification by
Product & Service - Instruments, Consumables and Services
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2017

Table 81: UK 15-Year Perspective for Microbial Identification
by Product & Service - Percentage Breakdown of Value Sales for
Instruments, Consumables and Services for the Years 2012,
2018 & 2027

Table 82: UK Current & Future Analysis for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 83: UK Historic Review for Microbial Identification by
End-Use - Hospitals, Diagnostic Laboratories, & Blood Banks,
Food Manufacturing Companies, Beverage Manufacturers,
Pharmaceutical Companies & CROs and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 84: UK 15-Year Perspective for Microbial Identification
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Laboratories, & Blood Banks, Food Manufacturing
Companies, Beverage Manufacturers, Pharmaceutical Companies &
CROs and Other End-Uses for the Years 2012, 2018 & 2027

REST OF EUROPE
Table 85: Rest of Europe Current & Future Analysis for
Microbial Identification by Product & Service - Instruments,
Consumables and Services - Independent Analysis of Annual Sales
in US$ Billion for the Years 2018 through 2027

Table 86: Rest of Europe Historic Review for Microbial
Identification by Product & Service - Instruments, Consumables
and Services Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 87: Rest of Europe 15-Year Perspective for Microbial
Identification by Product & Service - Percentage Breakdown of
Value Sales for Instruments, Consumables and Services for the
Years 2012, 2018 & 2027

Table 88: Rest of Europe Current & Future Analysis for
Microbial Identification by End-Use - Hospitals, Diagnostic
Laboratories, & Blood Banks, Food Manufacturing Companies,
Beverage Manufacturers, Pharmaceutical Companies & CROs and
Other End-Uses - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 89: Rest of Europe Historic Review for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2017

Table 90: Rest of Europe 15-Year Perspective for Microbial
Identification by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories, & Blood Banks, Food
Manufacturing Companies, Beverage Manufacturers, Pharmaceutical
Companies & CROs and Other End-Uses for the Years 2012, 2018 &
2027

ASIA-PACIFIC
Table 91: Asia-Pacific Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 92: Asia-Pacific Historic Review for Microbial
Identification by Product & Service - Instruments, Consumables
and Services Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 93: Asia-Pacific 15-Year Perspective for Microbial
Identification by Product & Service - Percentage Breakdown of
Value Sales for Instruments, Consumables and Services for the
Years 2012, 2018 & 2027

Table 94: Asia-Pacific Current & Future Analysis for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 95: Asia-Pacific Historic Review for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2017

Table 96: Asia-Pacific 15-Year Perspective for Microbial
Identification by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories, & Blood Banks, Food
Manufacturing Companies, Beverage Manufacturers, Pharmaceutical
Companies & CROs and Other End-Uses for the Years 2012, 2018 &
2027

REST OF WORLD
Table 97: Rest of World Current & Future Analysis for Microbial
Identification by Product & Service - Instruments, Consumables
and Services - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 98: Rest of World Historic Review for Microbial
Identification by Product & Service - Instruments, Consumables
and Services Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 99: Rest of World 15-Year Perspective for Microbial
Identification by Product & Service - Percentage Breakdown of
Value Sales for Instruments, Consumables and Services for the
Years 2012, 2018 & 2027

Table 100: Rest of World Current & Future Analysis for
Microbial Identification by End-Use - Hospitals, Diagnostic
Laboratories, & Blood Banks, Food Manufacturing Companies,
Beverage Manufacturers, Pharmaceutical Companies & CROs and
Other End-Uses - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 101: Rest of World Historic Review for Microbial
Identification by End-Use - Hospitals, Diagnostic Laboratories, &
Blood Banks, Food Manufacturing Companies, Beverage
Manufacturers, Pharmaceutical Companies & CROs and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2017

Table 102: Rest of World 15-Year Perspective for Microbial
Identification by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories, & Blood Banks, Food
Manufacturing Companies, Beverage Manufacturers, Pharmaceutical
Companies & CROs and Other End-Uses for the Years 2012, 2018 &
2027

IV. COMPETITION
Total Companies Profiled: 56
Read the full report: https://www.reportlinker.com/p05957365/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001